Two stages of cancer prevention with green tea

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 11, 1999, Pages 589-597

  Fujiki, Hirota ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ACETYLSALICYLIC ACID; ALITRETINOIN; ALLIIN; ALPHA TOCOPHEROL; BETA CAROTENE; CALCIUM; CURCUMIN; EFLORNITHINE; EPIGALLOCATECHIN GALLATE; FENRETINIDE; FINASTERIDE; GENISTEIN; IBUPROFEN; ISOTRETINOIN; KAVA; NATURAL PRODUCT; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; PERILLYL ALCOHOL; PHENETHYL ISOTHIOCYANATE; PIROXICAM; POLYPHENOL DERIVATIVE; PRASTERONE; RETINOIC ACID; RETINOID DERIVATIVE; RETINOL; RETINOL PALMITATE; SULINDAC; TAMOXIFEN; UNINDEXED DRUG;

APOPTOSIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; DRUG POTENTIATION; HUMAN; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; REVIEW; TEA;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; CATECHIN; CELL DIVISION; COHORT STUDIES; DRUG SYNERGISM; FEMALE; HUMANS; KAVA; MALE; NEOPLASMS; PHYTOTHERAPY; PLANTS, MEDICINAL; PROSPECTIVE STUDIES; SULINDAC; TEA; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032730946     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050321     Document Type: Review

References (69)

1. Achenbach H, Karl W, Regel W (1972) 11-Hydroxy-12-methoxydihydrokawain und 11.12-Dimethoxydihydrokawain, zwei neue Kawa-Lactone aus Rauschpfeffer (Piper methysticum Forst.). Chem Ber 105:2182-2187
2. Belman S (1983) Onion and garlic oils inhibit tumor promotion. Carcinogenesis 4:1063-1065
3. Bradfield CA, Bjeldanes LF (1987) High-performance liquid chromatographic analysis of anticarcinogenic indoles in Brassica oleracea. J Agric Food Chem 35:46-49
4. Buttery RG, Guadagni DG, Ling LC, Seifert RM, Lipton W (1976) Additional volatile components of cabbage, broccoli, and cauliflower. J Agric Food Chem 24:829-832
5. Cao Y, Cao R (1999) Angiogenesis inhibited by drinking tea. Nature 398:381
6. Chen W, Dong Z, Valcic S, Timmermann BN, Bowden GT (1999) Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog 24:79-84
7. Conney AH, Lou YR, Xie J-G, Osawa T, Newmark HL, Liu Y, Chang RL, Huang M-T (1999) Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med (in press)
8. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N, and other National Surgical Adjuvant Breast and Bowel Project Investigators (1998) Tamoxifen for prevention of breast cancer. Report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 90:1371-1388
9. Fujiki H, Okuda T (1992) (-)-Epigallocatechin gallate. Drugs Future 17:462-464
10. Fujiki H, Suganuma M (1993) Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv Cancer Res 61:143-194
11. Fujiki H, Suganuma M (1999) Unique features of the okadaic acid activity class of tumor promoters. J Cancer Res Clin Oncol 125:150-155
12. Fujiki H, Yoshizawa, S, Horiuchi T, Suganuma M, Yatsunami J, Nishiwaki S, Okabe S, Nishiwaki-Matsushima R, Okuda T, Sugimura T (1992) Anticarcinogenic effects of (-)-epigallocatechin gallate. Prev Med 21:503-509
13. Fujiki H, Suganuma M, Okabe S, Komori A, Sueoka E, Sueoka N, Kozu T, Sakai Y (1996) Japanese green tea as a cancer preventive in humans. Nutr Rev 54:S67-S70
14. Fujiki H, Komori, A, Suganuma M (1997) Chemoprevention of cancer. In: Bowden GT, Fischer SM (eds) Comprehensive toxicology, vol 12. Pergamon, Cambridge, pp 453-471
15. Fujiki H, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, Kozu T, Tada Y, Suga K, Imai K, Nakachi K (1998) Cancer inhibition by green tea. Mutat Res 402:307-310
16. Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K (1999a) A new concept of tumor promotion by tumor necrosis factor-α, and cancer preventive agents (-)-epigallocatechin gallate and green tea. Cancer Detect Prev (in press)
17. Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K, Kimura S (1999b) Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220:225-228
18. Guy GR, Cao X, Chua SP, Tan YH (1992) Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 267:1846-1852
19. Hamilton-Miller JMT (1995) Antimicrobial properties of tea (Camellia sinensis L.). Antimicrobial Agents Chemother 39:2375-2377
20. Henderson BE, Kolonel LN, Dworsky R, Kerford D, Mori E, Singh K, Thevenot H (1985) Cancer incidence in the islands of the Pacific. Natl Cancer Inst Monogr 69:73-81
21. Hescheler J, Mieskes G, Ruegg JC, Takai A, Trautwein W (1988) Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflugers Arch 412:248-252
22. Hong WK, Sporn MB (1997) Recent advances in chemoprevention of cancer. Science 278:1073-1077
23. IARC Working Group (1991) Tea. IARC Monogr 51:207-271
24. Imai K, Nakachi K (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. Br Med J 310:693-696
25. Imai K, Suga K, Nakachi K (1997) Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26:769-775
26. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E (1997) Why drinking green tea could prevent cancer. Nature 387:561
27. Karp F, Mihaliak CA, Harris JL, Croteau R (1990) Monoterpene biosynthesis: specificity of the hydroxylations of (-)-limonene by enzyme preparations from peppermint (Mentha piperita), spearmint (Mentha spicata), and perilla (Perilla frutescens) leaves. Arch Biochem Biophys 276:219-226
28. Kelloff GJ, Boone CW, Malone WF, Steele VE (1992) Chemoprevention clinical trials. Mutat Res 267:291-295
29. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, Malone WF, Hawk ET, Sigman CC (1996) New agents for cancer chemoprevention. J Cell Biochem 26S:1-28
30. Kelloff GJ, Hawk ET, Karp JE, Crowell JA, Boone CW, Steele VE, Lubet RA, Sigman CC (1997) Progress in clinical chemoprevention. Semin Oncol 24:241-252
31. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sasaki K, Fujiki H (1993) Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 53:1982-1985
32. Naasani I, Seimiya H, Tsuruo T (1998) Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem Biophys Res Commun 249:391-396
33. Naim M, Gestetner B, Kirson I, Birk Y, Bondi A (1973) A new isoflavone from soya beans. Phytochemistry 12:169-170
34. Nakachi K, Imai K, Suga K (1997a) Epidemiological evidence for prevention of cancer and cardiovascular disease by drinking green tea. In: Ohigashi H, Osawa T, Terao J, Watanabe S, Yoshikawa T (eds) Food factors for cancer prevention. Springer, Tokyo, pp 105-108
35. Nakachi K, Imai K, Suga K (1997b) Cancer-preventive effects of drinking green tea in a Japanese population. Proc Am Assoc Cancer Res 38:261
36. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89:254-261
37. NCI, DCPC, Chemoprevention Branch and Agent Development Committee (1996) Clinical development plan: tea extracts green tea polyphenols epigallocatechin gallate. J Cell Biochem 26S:236-257
38. Newman RA, Hutto T, Felix E, Lee JS, Pisters KMW, Hong WK (1999) Clinical pharmacology of catechins and caffeine in adult solid tumor patients enrolled in a phase I trial of green tea extract. Proc Am Assoc Cancer Res 40:82
39. Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, Kohyama K, Ishikawa T, Carmichael WW, Fujiki H (1992) Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol 118:420-424
40. Ohta T, Sueoka E, Iida N, Komori A, Suganuma M, Nishiwaki R, Tatematsu M, Kim SJ, Carmichael WW, Fujiki H (1994) Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res 54:6402-6406
41. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H (1997) Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 88:639-643
42. Okabe S, Ochiai Y, Aida M, Park K, Kim SJ, Nomura T, Suganuma M, Fujiki H (1999) Mechanistic aspects of green tea as cancer preventive on human stomach cancer cell lines. Jpn J Cancer Res 90:733-739
43. Okuda T, Mori K, Hayatsu H (1984) Inhibitory effect of tannins on direct-acting mutagens. Chem Pharm Bull (Tokyo) 32:3755-3758
44. Okuda T, Mori K, Hatano T (1985) Relationship of the structure of tannins to the binding activities with hemoglobin and methylene blue. Chem Pharm Bull (Tokyo) 33:1424-1433
45. Ren Z, Gould MN (1994) Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol. Cancer Lett 76:185-190
46. Slaughter DP, Southmick HW, Smeikal W (1953) "Field cancerization" in oral stratified squamous epithelium. Cancer 6:963-968
47. Sotheeswaran S (1987) Kawa and the Australian aborigine. Chem Australia, Oct:377-378
48. Spence RMM, Tucknott OG (1983) An apparatus for the comparative collection of headspace volatiles of watercress. J Sci Food Agric 34:412-416
49. Sporn MB (1993) Chemoprevention of cancer. Lancet 342:1211-1213
50. Sporn MB, Dunlop NM, Newton DL, Smith JM (1976) Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35:1332-1338
51. Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, Sigman CC, Boone CW, Kelloff GJ (1994) Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem 20:32-54
52. Steele VE, Sharma S, Mehta R, Elmore E, Radpath L, Rudd C, Bagheri D, Sigman CC, Kelloff GJ (1996) Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cell Biochem 26S:29-53
53. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K, Sugimura T (1988) Okadaic acid: an additional non-phorbol-12-tetrade-canoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768-1771
54. Suganuma M, Tatematsu M, Yatsunami J, Yoshizawa S, Okabe S, Uemura D, Fujiki H (1992) An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis 13:1841-1845
55. Suganuma M, Okabe S, Sueoka E, Nishiwaki R, Komori A, Uda N, Isono K, Fujiki H (1995) Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach., J Cancer Res Clin Oncol 121:621-627
56. Suganuma M, Okabe S, Sueoka E, Iida N, Komori A, Kim S-J, Fujiki H (1996) A new process of cancer prevention mediated through inhibition of tumor necrosis factor α expression. Cancer Res 56:3711-3715
57. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19:1771-1776
58. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H (1999a) Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in human lung cancer cell line PC-9. Cancer Res 59:44-47
59. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H (1999b) Essential role of tumor necrosis factor-α in tumor promotion as revealed by TNF-α deficient mice. Cancer Res (in press)
60. Troll W, Lim JS, Belman S (1992) Protease inhibitors suppress carcinogenesis in vivo and in vitro. In: Wattenberg LW, Lipkin M, Boone CW, Kelloff GJ (eds) Cancer Chemoprevention. CRC, Boca Raton Fla pp 503-512
61. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smith AMM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
62. Wattenberg LW (1983) Inhibition of neoplasia by minor dietary constituents. Cancer Res 43:2448s-2453s
63. Wattenberg LW (1993) Prevention-therapy-basic science and the resolution of the cancer problem: presidential address. Cancer Res 53:5890-5896
64. Wattenberg LW, Lipkin M, Boone CW, Kelloff GJ (eds) (1992) Cancer chemoprevention CRC, Boca Raton, Fla
65. Weinstein IB, Begemann M, Zhou P, Han EK-H, Sgambato A, Doki Y, Arber N, Ciaparrone M, Yamamoto H (1997) Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin Cancer Res 3:2696-2702
66. Weisburger J (ed) (1999) Proceedings of the Society For Experimental Biology and Medicine vol 220. Blackwell Science, New York, NY
67. Yang CS, Wang Z-Y (1993) Tea and cancer. J Natl Cancer Inst 85:1038-1049
68. Yoshizawa S, Horiuchi T, Fujiki H, Yoshida T, Okuda T, Sugimura T (1987) Antitumor promoting activity of (-)-epigallocatechin gallate, the main constituent of "tannin" in green tea. Phytother Res 1:44-47
69. Young TB, Wolf DA (1988) Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int J Cancer 42:167-175